- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Corcept Therapeutics reports positive phase 3 results in ovarian cancer treatment | ||
| Fr | ProImmune expands into new global headquarters in Oxford | ||
| Do | Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn | ||
| Do | Excellence in Healthcare Partnerships (EHP) Awards Networking Event | ||
| Mi | ViiV Healthcare receives NICE recommendation for HIV prevention therapy | ||
| Mi | Aqilion announces positive results from eosinophilic esophagitis treatment study | ||
| Di | Sanofi reports improved patient outcomes from high-dose influenza vaccine | ||
| Di | Mainz Biomed reports on blood-based screening test for pancreatic cancer | ||
| Mo | Mission Therapeutics advances Parkinson's disease candidate | ||
| Mo | ISPEP launches International Patient Engagement Day 2025 | ||
| 17.10. | Pelage Pharmaceuticals' alopecia treatment moves forward to phase 3 trial | ||
| 17.10. | MHRA marks 100 years of patient safety through biological standards | ||
| 17.10. | Bridging the evidence-to-practice gap in healthcare | ||
| 16.10. | BMS acquires Orbital Therapeutics in $1.5bn deal | ||
| 16.10. | Lilly and WHO Foundation partner to support global dementia action plan | ||
| 16.10. | Transforming pharma: the power of digital and AI engineering | ||
| 15.10. | AstraZeneca to invest $4.5bn in US manufacturing facility | ||
| 15.10. | Breast Cancer Awareness Month marked as London's King's Cross tunnel lights up in pink | ||
| 15.10. | Innovation, impact and the future: Communiqué Awards 2025 | ||
| 15.10. | Generative engine optimisation: closing AI gaps, creating market edge | ||
| 14.10. | La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars | ||
| 14.10. | Inizio announced as headline sponsor for 2026 Communiqué Awards | ||
| 14.10. | Bioxodes appoints Philippe Monteyne as new chairman of the board | ||
| 14.10. | Pre-commercial to launch-ready: four steps to sharpen strategy, execution and impact | ||
| 13.10. | David Weinreich appointed as Merck's head of R&D and CMO for healthcare |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .